24.08.2013 Views

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Clinical genetics<br />

matological anomalies . Almost 50% <strong>of</strong> patients with NS (sporadic or<br />

familial) carry an missense mutation <strong>of</strong> PTPN11 gene (12q24), while<br />

other genes ( KRAS and SOS1) play a minor role in the molecular<br />

pathogenesis <strong>of</strong> the disease .<br />

We present a familial case, mother and daughter, with NS diagnosed<br />

by used a scoring system based by clinical signs .<br />

The diagnosis was performed first in daughter, wich was identified at<br />

birth . She presented polihidramnyos, nuchal oedema and premature<br />

born . The patient was reevaluated <strong>of</strong> two months age . Clinical and<br />

paraclinic evaluation revealed the major features <strong>of</strong> NS: feeding difficulties<br />

with failure to thrive, short stature, typical facial dysmorphy (microcephaly,<br />

broad and high forehead, down-slanting palpebral fisusures,<br />

hypertelorism, epicanthic folds, micrognathia, low-set posteriorly<br />

rotated ears), short neck with excess nucal skin, pectus excavatum,<br />

Hypertrophic Obstructive Cardiomyopaty (HOMC) with asymmetrical<br />

septum hypertrophy and neuromotor retardation . Other feature was<br />

ombilical hernia . She had anemia, but no thrombocytopenia or other<br />

coagulation defect . Clinical genetic examination <strong>of</strong> mother (N .C .M .),<br />

31 years old, after delivery revealed the phenotype <strong>of</strong> NS (facial typical<br />

dysmorphysm, pterygium colli, pectus carinatum superior and excavatum<br />

inferior), pulmonar stenosis and mental retardation . The analysis<br />

<strong>of</strong> pedigree showed the absence <strong>of</strong> other cases in family .In conclusion,<br />

we emphasize, the importance <strong>of</strong> the clinical features for diagnosis,<br />

leading further to an aprropiate management and for according genetic<br />

counseling<br />

P01.179<br />

Noonan and cardio-facio-cutaneous syndromes: two clinically<br />

and Genetically Overlapping Disorders<br />

A. M. Nyström 1 , S. Ekvall 1 , E. Berglund 2 , M. Bjorkqvist 3 , G. Braathen 4 , K.<br />

Duchen 5 , H. Enell 6 , E. Holmberg 4 , U. Holmlund 7 , M. Olsson-Engman 8 , G. Annerén<br />

1 , M. L. Bondeson 1 ;<br />

1 Uppsala University, Uppsala, Sweden, 2 Central Hospital, Skelleftea, Sweden,<br />

3 University Hospial, Orebro, Sweden, 4 Sahlgrenska University Hospital, Gothenburg,<br />

Sweden, 5 University Hospital, Linkoping, Sweden, 6 Regional Hospital<br />

<strong>of</strong> Halmstad, Halmstad, Sweden, 7 Central Hospital, Vasteras, Sweden, 8 Regional<br />

Hospital <strong>of</strong> Karlskrona, Karlskrona, Sweden.<br />

Noonan and Cardio-facio-cutaneous (CFC) syndromes are related disorders<br />

associated with dysregulated RAS-MAPK signalling . Noonan<br />

syndrome (NS) is associated with mutations in the genes PTPN11,<br />

SOS1, KRAS and RAF1 . The genetic aetiology <strong>of</strong> the clinically overlapping<br />

CFC syndrome was recently assigned to four genes, BRAF,<br />

KRAS, MEK1 and MEK2 . Here, we present a comprehensive mutation<br />

analysis <strong>of</strong> BRAF, KRAS, MEK1, MEK2 and SOS1 in 31 unrelated NS/<br />

CFC patients without mutations in PTPN11. Mutations were identified<br />

in 8 patients, in whom we also present a detailed clinical investigation .<br />

Seven <strong>of</strong> the mutations were identified in patients with CFC diagnoses<br />

(2 in BRAF, 1 in KRAS, 1 in MEK1, 2 in MEK2 and 1 in SOS1) .<br />

Two mutations were novel: MEK1 E203Q and MEK2 F57L . The SOS1<br />

E433K mutation, identified in a patient diagnosed as CFC, has previously<br />

been reported in patients with NS . In one NS patient, we also<br />

identified a BRAF K499E mutation, previously reported in patients with<br />

CFC . We thus suggest involvement also <strong>of</strong> BRAF in the pathogenesis<br />

<strong>of</strong> NS .<br />

Taken together, our results indicate that the molecular and clinical<br />

overlap between CFC and NS is more complex than previously suggested<br />

and that the syndromes might even present as allelic disorders .<br />

Furthermore, we suggest that the diagnosis should be refined to, e.g.,<br />

NS-PTPN11-associated or CFC- BRAF-associated after the genetic<br />

defect has been established since this may have an impact on prognosis<br />

and treatment <strong>of</strong> the patients .<br />

P01.180<br />

clinical and molecular studies in 95 polish patients with noonan<br />

syndrome<br />

E. Obersztyn, J. Klapecki, M. Łaniewski -Wołłk, A. Szpecht - Potocka, J. Bal,<br />

T. Mazurczak;<br />

Institute <strong>of</strong> Mother and Child, Warsaw, Poland.<br />

Noonan syndrome (NS, OMIM 163950) is genetically heterogenous<br />

disorder characterized by facial dysmorphism, short stature, variety<br />

<strong>of</strong> heart defects (particularly pulmonary stenosis), chest deformations,<br />

pterygium colli, lymphatic dysplasia, cryptorchidism and psychomotor<br />

retardation . Heterogeneous mutations in PTPN11 gene are respon-<br />

sible for 29-60% <strong>of</strong> NS cases . The aim <strong>of</strong> our study was to estimate<br />

the frequency <strong>of</strong> PTPN11 gene mutations in Polish patients with NS .<br />

Results <strong>of</strong> clinical and molecular studies the group <strong>of</strong> 95 probands are<br />

reported . Detailed clinical evaluation, including family pedigree, dysmorphic<br />

features, pre- and postnatal development and congenital malformations<br />

is presented . Direct sequencing analysis <strong>of</strong> the 15 exons <strong>of</strong><br />

PTPN11 gene was performed and mutation was found in 32 (35%) <strong>of</strong><br />

the probands. The most frequent among 15 identified missense mutations<br />

were: 1510A>G and 922A>G . In 9(28%) patients mutation was<br />

familiar and in 77% <strong>of</strong> cases was maternal in origin .<br />

All patients with PTPN11 mutation demonstrated typical NS phenotype .<br />

Pulmonary valve stenosis, atrial septum defect, coagulation abnormalities,<br />

mild mental retardation, short triangular face with pointed chin<br />

were statistically the most frequent in patients with PTPN11 mutation .<br />

Statistically significant correlation <strong>of</strong> pulmonary stenosis with 922A>G<br />

and 1510A>G mutation was found . Heart defect was present in all probands<br />

with PTPN11 mutation, but only in 66% <strong>of</strong> their parents .<br />

We concluded that probably another mutations within SOS1, KRAS<br />

and BRAF genes involved in the RAS-MAPK pathway may be responsible<br />

for NS in subset <strong>of</strong> presented patients without PTPN11 mutation .<br />

Further investigations are planned to explain NS phenotype in these<br />

patients .<br />

P01.181<br />

sOs1 mutation as a cause for Noonan syndrome type 4: A report<br />

<strong>of</strong> two patients<br />

G. Yesil 1 , B. Tuysuz 1 , M. Zenker 2 ;<br />

1 Istanbul University, Cerrahpasa Faculty <strong>of</strong> Medicine, Istanbul, Turkey, 2 Universitatsklinikum<br />

Erlangen, <strong>Human</strong>genetisches Insitut, Erlangen, Germany.<br />

Noonan syndrome (NS) is an autosomal dominantly inherited disease<br />

characterized by mental retardation (25%), short stature, pterygium<br />

colli, congenital heart defect and hypogonadism . Approximately 50%<br />

<strong>of</strong> cases are caused by mutations in the PTPN11 gene on chromosome<br />

12q24 .1 . Recently, Roberts and Tartaglia (2007) found mutation<br />

in the SOS1 gene on chromosome 2p22 to be responsible from %20<br />

<strong>of</strong> NS who had ectodermal abnormalities but normal development .<br />

This subtype called NS4 which share many clinical features with a<br />

group <strong>of</strong> developmental disorders including Costello and CFC (Cardi<strong>of</strong>aciocutenous)<br />

syndrome. Our first patient was a 7 month old male<br />

and the second was 45 days old girl who had coarse face, sparse hair<br />

and eyebrows and skin loss . Valvular pulmonary stenosis was shown<br />

in echocardiography at the first patient and atrioventricular channel<br />

defect and pulmonary hypertension at the second . One <strong>of</strong> our patients<br />

had signs <strong>of</strong> hyperkeratotic skin too . SOS 1 mutation were detected on<br />

exon 6; c .797C-> A heterozygous, p .T266K and on exon16 c .2536G>A<br />

heterozygous p .E846K in patient 1 and patient 2 respectively . Pulmonary<br />

stenosis was found more frequently in patients with SOS1 mutations<br />

than PTPN1 mutations and atrial septal defect was relatively rare<br />

in affected individuals with SOS1 mutations . Thus clinical examination<br />

can be indeterminative . It is important to remember to identify SOS1<br />

gene on patients who are free <strong>of</strong> BRAF, KRAS, MEK 1, 2 mutations<br />

that are responsible from the etiology <strong>of</strong> CFC syndrome .<br />

P01.182<br />

Prenatal images and evolution to cutis verticis gyrata in a<br />

newborn with Noonan syndrome<br />

A. Moresco 1 , J. van der Velde 2 , M. Ingilde 2 , G. Chernovetzky 2 , S. Naddeo 2 , S.<br />

Spinelli 2 , M. Rittler 2 ;<br />

1 Centro Nacional de Genética Médica, Buenos Aires, Argentina, 2 Grupo de<br />

Diagnóstico Prenatal. Hospital Materno Infantil Ramón Sardá, Buenos Aires,<br />

Argentina.<br />

Cutis verticis gyrata (CVG) is a rare defect, characterized by skin ridges<br />

and<br />

furrows forming cerebriform folds . Its primary form is associated with<br />

neuropsychiatric disorders or genetic syndromes, such as Turner and,<br />

more rarely, Noonan . Secondarily, CVG may be due to a local process<br />

or a systemic illness .<br />

Objective: To show the prenatal images <strong>of</strong> CVG in a fetus, and its<br />

evolution until birth, when Noonan syndrome was diagnosed .<br />

case report: The propositus was the third child <strong>of</strong> a young and healthy<br />

couple . Pregnancy was uneventful until 18 gestational weeks, when an<br />

ultrasound (US) scan revealed a cystic hygroma, hydrothorax and a<br />

fluid collection at the cephalic pole, which first suggested an underlying

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!